CIK 0001754068
- Non-accelerated filer
- Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831971007
- Phone
- +1 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- 4 Open-market sale Chief Executive Officer sold 5,149 shares at $0.79 ($4,080)
- 4 Open-market sale Chief Accounting Officer sold 541 shares at $0.75 ($405)
- 4 Open-market sale Chief Executive Officer sold 3,075 shares at $0.75 ($2,304)
- 4 Open-market sale Sinha Vikas sold 3,143 shares at $0.75 ($2,355)
- 4 Open-market sale General Counsel sold 420 shares at $0.75 ($315)
- 4 Open-market sale Chief Executive Officer sold 10,240 shares at $0.80 ($8,151)
- 4 Open-market sale Chief Accounting Officer sold 1,597 shares at $0.80 ($1,271)
- 4 Open-market sale Sinha Vikas sold 4,957 shares at $0.80 ($3,946)
- 4 Open-market sale General Counsel sold 2,311 shares at $0.80 ($1,840)
- 4 Open-market sale Chief Accounting Officer sold 953 shares at an average $0.75 ($715)
- 4 Open-market sale General Counsel sold 1,383 shares at an average $0.75 ($1,038)
- 4 Open-market sale Chief Executive Officer sold 9,601 shares at $0.75 ($7,207)
- 4 Open-market sale Sinha Vikas sold 3,378 shares at an average $0.75 ($2,534)
- 4 Open-market sale General Counsel sold 368 shares at $0.77 ($284)
- 4 Open-market sale Chief Executive Officer sold 1,533 shares at $0.77 ($1,183)
- 4 Open-market sale Chief Accounting Officer sold 281 shares at $0.77 ($217)
- 4 Open-market sale Sinha Vikas sold 885 shares at $0.77 ($683)
- 4 Open-market sale Chief Executive Officer sold 8,252 shares at an average $0.70 ($5,803)
- 4 Open-market sale General Counsel sold 385 shares at $0.70 ($268)
- 4 Open-market sale Sinha Vikas sold 2,893 shares at $0.70 ($2,011)
Page 6 of 19 · 363 filings